Showing results (1411-1420 of 1,438) with videos related to

Sort By:
Pageof 144
Science China. Life Sciences|September 14, 2025
A novel pathologic scoring system for predicting postoperative recurrence in BCLC stage 0-A hepatocellular carcinoma patients: a nationwide multicenter studyFeng Xia, Jing Yan, Xulin Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2022
A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell CarcinomaYujin Xu, Baiqiang Dong, Weiguo Zhu, et al.
BMJ (Clinical Research Ed.)|January 7, 2026
Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trialChunjuan Wang, Hongqiu Gu, Xiaochuan Huo, et al.
BMJ (Clinical Research Ed.)|March 20, 2026
Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trialXinmiao Zhang, Lingling Ding, Jing Jing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2024
Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III TrialHongfu Sun, Minghao Li, Wei Huang, et al.
Lancet (London, England)|February 8, 2026
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trialYunyun Xiong, Fana Alemseged, Zhixin Cao, et al.
Frontiers in Oncology|March 22, 2021
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre AnalysisQitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Frontiers in Oncology|June 13, 2020
Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre AnalysisQitong Chen, Dengjie Ouyang, Munawar Anwar, et al.
Frontiers in Neurology|April 19, 2021
Association of Trimethylamine N-Oxide and Its Precursor With Cerebral Small Vessel Imaging MarkersYiyi Chen, Jie Xu, Yuesong Pan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter DataMunawar Anwar, Qitong Chen, Dengjie Ouyang, et al.
Pageof 144